Evidence map›Paper›PMID 33595068›Full record

ArticleSchizophrenia bulletin2021

Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia.

Shabeesh Balan, Tetsuo Ohnishi, Akiko Watanabe, Hisako Ohba, Yoshimi Iwayama, Manabu Toyoshima, Tomonori Hara, Yasuko Hisano, Yuki Miyasaka, Tomoko Toyota and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Posterior segment findings in a patient with aAmerican journal of ophthalmology case reports · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Shabeesh BalanLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.ORCID 0000-0002-1098-1290
Tetsuo OhnishiLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Akiko WatanabeLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Hisako OhbaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Yoshimi IwayamaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Manabu ToyoshimaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Tomonori HaraLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Yasuko HisanoLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Yuki MiyasakaDeafness Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, Japan.
Tomoko ToyotaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Chie Shimamoto-MitsuyamaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Motoko MaekawaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Shusuke NumataDepartment of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Tetsuro OhmoriDepartment of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Tomomi ShimogoriLaboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Wako, Saitama, Japan.
Yoshiaki KikkawaDeafness Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Tokyo, Japan.
Takeshi HayashiAgricultural Artificial Intelligence (AI) Research Office, Research Center for Agricultural Information Technology, National Agriculture and Food Research Organization (NARO), Tokyo, Japan.
Takeo YoshikawaLaboratory for Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.ORCID 0000-0003-2791-6679
RIKEN Center for Brain Science · JPTokushima University · JPTokyo Metropolitan Institute of Medical Science · JPNational Agriculture and Food Research Organization · JPOchanomizu University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously identified quantitative trait loci (QTL) for prepulse inhibition (PPI), an endophenotype of schizophrenia, on mouse chromosome 10 and reported Fabp7 as a candidate gene from an analysis of F2 mice from inbred strains with high (C57BL/6N; B6) and low (C3H/HeN; C3H) PPI levels. Here, we reanalyzed the previously reported QTLs with increased marker density. The highest logarithm of odds score (26.66) peaked at a synonymous coding and splice-site variant, c.753G>A (rs257098870), in the Cdh23 gene on chromosome 10; the c.753G (C3H) allele showed a PPI-lowering effect. Bayesian multiple QTL mapping also supported the same variant with a posterior probability of 1. Thus, we engineered the c.753G (C3H) allele into the B6 genetic background, which led to dampened PPI. We also revealed an e-QTL (expression QTL) effect imparted by the c.753G>A variant for the Cdh23 expression in the brain. In a human study, a homologous variant (c.753G>A; rs769896655) in CDH23 showed a nominally significant enrichment in individuals with schizophrenia. We also identified multiple potentially deleterious CDH23 variants in individuals with schizophrenia. Collectively, the present study reveals a PPI-regulating Cdh23 variant and a possible contribution of CDH23 to schizophrenia susceptibility.

Indexed as

AllelesAnimalsCadherin Related ProteinsCadherinsHumansMicePrepulse InhibitionQuantitative Trait LociSchizophreniaCadherin Related ProteinsCadherinsCDH23 protein, humanCdh23 protein, mouseCdh23 (CDH23)hearing lossprepulse inhibitionquantitative trait locusschizophrenia

Identifiers

PMID33595068
PMCPMC8266601
OpenAlexW3101710359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.